ORPHAN REACH

• 72190 - Other research and experimental development on natural sciences and engineering

Orphan Reach is the result of 19 years of international trial experience which has started as QED Clinical Services and was initially established as a functional service provider for the pharmaceutical industry. QED quickly evolved into a niche CRO known for rescuing clinical studies from other CROs where patient recruitment and retention were the main challenges. Many of these projects have been conducted in smaller patient populations, particularly in rare diseases where larger service providers struggled to find the optimal development strategy... Navigating the CRO landscape can be difficult for biotech companies that vastly rely on outsourcing as the differentiation between CROs seems marginal and confusing at times. Orphan Reach is different: We are a boutique service provider solely focused on orphan product candidates supported by a competent team of experts in the field of rare diseases. Our name is our mission... With Orphan Reach we offer a global, dedicated and patient..

Also known as: EMMES BIOPHARMA UK LIMITED

Previous names: ORPHAN REACH LIMITED, QED CLINICAL SERVICES LIMITED

Registration numbers: 04498663 (CH), 4498663 (W)

VAT numbers: GB812185451

Primary location: Milton Keynes United Kingdom